Strategic trends, current and future competitive landscape in biologics and biosimilars

---

Yavuz S Silay

MaQasid Angel Investors Network, Turkey

: J Pharm Drug Deliv Res

Abstract

---

Investment Groups, VCs , Angel Investor Networks, Large Pharmaceutical, Biotech and Medical Device companies are constantly evaluating how to work with universities and startup companies and utilize their know how. MAIN(MaQasid Angel Investors Network) in collaboration with Incubation İstanbul recently worked at Istanbul Aydın University to establish a thematic program in Healthcare Bioentrepreneurship which has taken the road with the slogan of "Towards a Bright Future", at the brightest spots of business life. Istanbul Aydın University is a city and campus university located in the center of Istanbul with its experienced academic staff who have gained a reputation for their scientific studies globally. At BioCube İstanbul several healthcare startup companies are flourishing thanks to the coordination of Technology Transfer and Project Managament offices succesful coordination on innovation management with all key stakeholders To gain these critical insights for Thematic Management of Healthcare Bioentrepreneurship and Innovation Track in Universities and how to accelerate innovations in order to improve healthcare. We seek to empower entrepreneur academicians, doctors, other healthcare providers and with the information, resources, connections, and experience they need to commercialize their ideas, inventions and discoveries. Current Trends in Innovation Management in Medicine in a University Setting and the BioCube İstanbul Bioentrepreneurship and Innovation Center as a global success case for USA Europe Turkey and Emerging Markets will be provided with unique cases within an investor physician perspective.

Biography

---

Yavuz S Silay is the Co-Founder & CEO of MAIN(MaQasid Angel Investors Network) & chairman of Istanbul Consulting Group. ICG(Istanbul Consulting Group) which was founded in 2013 and provided guidance to the Turkish ministry of health as part of a World Bank project. Yavuz is currently the Co-Founder of BioCube Ä°stanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of Sumitomo Group/ Expel Ä°laç Archem Diagnostices Endmed and Diagen.